調查批次:CHT2014-10 | 檢體寄出日期:2014-10-01 | 報告回收截止日期:2014-10-08 | 回收份數:21 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
1 |
3 |
22.0 |
6.4 |
41.0 |
5.1 |
1.0 |
171 |
6.4 |
1.5 |
30.6 |
3.8 |
0.2 |
128 |
RH07b | RH07 | 6 |
1 |
3 |
21.8 |
6.2 |
39.7 |
5.0 |
0.8 |
165 |
6.8 |
1.9 |
38.8 |
4.9 |
1.0 |
162 |
RH14 | RH14 | 6 |
1 |
3 |
18.1 |
2.5 |
16.0 |
2.0 |
-1.4 |
67 |
6.1 |
1.2 |
24.5 |
3.1 |
-0.4 |
103 |
RH15 | RH15 | 6 |
1 |
3 |
20.7 |
5.1 |
32.7 |
4.1 |
0.2 |
136 |
6.3 |
1.4 |
28.6 |
3.6 |
0.0 |
120 |
CL009 | CL009 | 5 |
1 |
3 |
21.5 |
5.9 |
37.8 |
4.7 |
0.7 |
157 |
6.5 |
1.6 |
32.7 |
4.1 |
0.4 |
137 |
CL010 | CL010 | 2 |
1 |
3 |
21.1 |
5.5 |
35.3 |
4.4 |
0.4 |
147 |
6.6 |
1.7 |
34.7 |
4.4 |
0.6 |
145 |
CL012 | CL012 | 5 |
1 |
3 |
19.9 |
4.3 |
27.6 |
3.4 |
-0.3 |
115 |
5.7 |
0.8 |
16.3 |
2.1 |
-1.2 |
68 |
CL013 | CL013 | 5 |
1 |
5 |
16.8 |
1.2 |
7.7 |
1.0 |
-2.2 |
32 |
4.8 |
-0.1 |
-2.0 |
-0.3 |
-3.1 |
-9 |
CL014a | CL014 | 5 |
1 |
3 |
19.6 |
4.0 |
25.6 |
3.2 |
-0.5 |
107 |
6.2 |
1.3 |
26.5 |
3.3 |
-0.2 |
111 |
CL015 | CL015 | 7 |
1 |
3 |
21.0 |
5.4 |
34.6 |
4.3 |
0.4 |
144 |
6.9 |
2.0 |
40.8 |
5.1 |
1.2 |
171 |
Median of RIA Group |
20.9 |
6.4 |
||||||||||||||
Range of RIA Group |
16.8 - 22.0 |
4.8 - 6.9 |
||||||||||||||
Robust mean of RIA Group |
20.4 ( n = 10 ) |
6.3 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
1.66 |
0.49 |
||||||||||||||
CV of RIA Group |
8.1% |
7.8% |
||||||||||||||
Median of European RIA Labs |
15.8 ( n = 106 ) |
5.0 ( n = 106 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
14.8 - 20.7 |
4.4 - 6.5 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 5 |
3 |
9 |
15.5 |
-0.1 |
-0.6 |
-0.1 |
1.3 |
-3 |
4.9 |
0.0 |
0.0 |
0.0 |
1.0 |
0 |
RH02c | RH02 | 5 |
3 |
1 |
12.6 |
-3.0 |
-19.2 |
-2.4 |
-1.4 |
-80 |
4.0 |
-0.9 |
-18.4 |
-2.3 |
-1.3 |
-77 |
RH06 | RH06 | 2 |
3 |
9 |
13.3 |
-2.3 |
-14.7 |
-1.8 |
-0.7 |
-61 |
4.7 |
-0.2 |
-4.1 |
-0.5 |
0.5 |
-17 |
RH07a | RH07 | 2 |
3 |
2 |
13.8 |
-1.8 |
-11.5 |
-1.4 |
-0.3 |
-48 |
4.2 |
-0.7 |
-14.3 |
-1.8 |
-0.8 |
-60 |
RH12 | RH12 | 2 |
3 |
2 |
14.3 |
-1.3 |
-8.3 |
-1.0 |
0.2 |
-35 |
4.9 |
0.0 |
0.0 |
0.0 |
1.0 |
0 |
RH19 | RH19 | 3 |
3 |
2 |
13.5 |
-2.1 |
-13.5 |
-1.7 |
-0.6 |
-56 |
4.6 |
-0.3 |
-6.1 |
-0.8 |
0.2 |
-26 |
RH20 | RH20 | 5 |
3 |
7 |
13.4 |
-2.2 |
-14.1 |
-1.8 |
-0.7 |
-59 |
4.5 |
-0.4 |
-8.2 |
-1.0 |
0.0 |
-34 |
CL005 | CL005 | 1 |
3 |
9 |
14.8 |
-0.8 |
-5.1 |
-0.6 |
0.7 |
-21 |
4.0 |
-0.9 |
-18.4 |
-2.3 |
-1.3 |
-77 |
CL006a | CL006 | 7 |
3 |
7 |
14.1 |
-1.5 |
-9.6 |
-1.2 |
0.0 |
-40 |
4.4 |
-0.5 |
-10.2 |
-1.3 |
-0.2 |
-43 |
CL008 | CL008 | 7 |
3 |
2 |
13.7 |
-1.9 |
-12.2 |
-1.5 |
-0.4 |
-51 |
4.5 |
-0.4 |
-8.2 |
-1.0 |
0.0 |
-34 |
CL011 | CL011 | 0 |
3 |
13 |
15.9 |
0.3 |
1.9 |
0.2 |
1.7 |
8 |
5.0 |
0.1 |
2.0 |
0.3 |
1.3 |
9 |
Median of CLIA Group |
13.8 |
4.5 |
||||||||||||||
Range of CLIA Group |
12.6 - 15.9 |
4.0 - 5.0 |
||||||||||||||
Robust mean of CLIA Group |
14.1 ( n = 11 ) |
4.5 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
1.07 |
0.40 |
||||||||||||||
CV of CLIA Group |
7.6% |
8.9% |
||||||||||||||
Median of European CLIA Labs |
15.6 ( n = 1203 ) |
5.0 ( n = 1203 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
13.0 - 16.7 |
4.2 - 5.3 |
||||||||||||||
Median of All Labs |
15.9 |
4.9 |
||||||||||||||
Range of All Labs |
12.6 - 22.0 |
4.0 - 6.9 |
||||||||||||||
Robust mean of All Labs |
17.0 ( n = 21 ) |
5.3 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
3.88 |
1.13 |
||||||||||||||
CV of All Labs |
22.8% |
21.3%
|
||||||||||||||
Median of All European Labs ( Xa ) |
15.6 |
4.9 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
13.1 - 16.9 |
4.2 - 5.3 |
||||||||||||||
Mean of All European Labs |
15.4 ( n = 1430 ) |
4.8 ( n = 1430 ) |
||||||||||||||
SD of All European Labs |
2.06 |
0.64 |
||||||||||||||
CV of All European Labs |
13.4% |
13.2% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
1.248 |
0.392 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Immunotech |
5 |
CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-10-14